###begin article-title 0
###xml 75 80 <span type="species:ncbi:9606">Human</span>
BDCA2/FcepsilonRIgamma Complex Signals through a Novel BCR-Like Pathway in Human Plasmacytoid Dendritic Cells
###end article-title 0
###begin p 1
###xml 123 128 <span type="species:ncbi:9606">Human</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
Dendritic cells are equipped with lectin receptors to sense the extracellular environment and modulate cellular responses. Human plasmacytoid dendritic cells (pDCs) uniquely express blood dendritic cell antigen 2 (BDCA2) protein, a C-type lectin lacking an identifiable signaling motif. We demonstrate here that BDCA2 forms a complex with the transmembrane adapter FcepsilonRIgamma. Through pathway analysis, we identified a comprehensive signaling machinery in human pDCs, similar to that which operates downstream of the B cell receptor (BCR), which is distinct from the system involved in T cell receptor (TCR) signaling. BDCA2 crosslinking resulted in the activation of the BCR-like cascade, which potently suppressed the ability of pDCs to produce type I interferon and other cytokines in response to Toll-like receptor ligands. Therefore, by associating with FcepsilonRIgamma, BDCA2 activates a novel BCR-like signaling pathway to regulate the immune functions of pDCs.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 417 422 <span type="species:ncbi:9606">Human</span>
###xml 750 755 <span type="species:ncbi:9606">human</span>
Dendritic cells (DCs) are specialized sentinels in the immune system that detect invading pathogens and, upon activation, initiate immune responses. DCs express C-type lectin receptors on their surface, which facilitate antigen capture. A distinct population of DCs, called plasmacytoid DCs (pDCs), display an extraordinary ability to rapidly make huge amounts of antiviral interferon (IFN) against viral infections. Human pDCs uniquely express a C-type lectin named BDCA2 that potently regulates pDCs function, yet the mechanism of how BDCA2 transduces signals is unknown. We show here that BDCA2 forms a complex with the transmembrane adapter FcepsilonRIgamma. Using signaling pathway analysis, we discovered a comprehensive signaling machinery in human pDCs, similar to that which operates downstream of B cell receptors (BCRs), but distinct from the pathway involved in T cell receptor signaling. By associating with FcepsilonRIgamma, BDCA2 activates a novel BCR-like signaling pathway to regulate the immune functions of pDCs. Since several pDC receptors use this pathway to modulate IFN and cytokine responses, these findings will guide more studies on how pDCs are regulated. Such mechanisms may lead to potential therapeutic interventions in autoimmune diseases involving hyperactivated pDCs, such as systemic lupus erythematosus and psoriasis.
###end p 4
###begin p 5
Plasmacytoid dendritic cells (pDCs) are renowned for their production of type 1 interferon in response to viral infection, which is signified by Toll-like receptor (TLR) activation. Here, blood dendritic cell antigen 2(BDCA2), a C-type lectin receptor expressed uniquely on pDCs, is shown to block the ultimate effectors of TLR signaling via a novel pathway.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b001">1</xref>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b003">3</xref>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b004">4</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b005">5</xref>
###xml 481 482 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b006">6</xref>
###xml 889 890 889 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b006">6</xref>
###xml 1045 1046 1045 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b003">3</xref>
###xml 1047 1048 1047 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b004">4</xref>
###xml 1205 1206 1205 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b003">3</xref>
###xml 1207 1208 1207 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b004">4</xref>
###xml 397 402 <span type="species:ncbi:10090">mouse</span>
###xml 896 902 <span type="species:ncbi:9606">humans</span>
Dendritic cells (DCs) are specialized sentinels in the immune system that detect invading pathogens and pathological damages of the host. Upon activation, DCs instruct appropriate and effective immune responses [1-3]. Their extraordinary ability to capture antigens (self or foreign) is largely mediated by the collective expression of C-type lectin receptors (CLRs) on the cell surface [4,5]. In mouse spleen, DC subsets display a discrete expression profile of C-type lectins-CD8+ DCs express DEC-205 (CD205), whereas CD8- DCs express dendritic cell immunoreceptor 2 (DCIR2), dendritic cell immunoactivating receptor (DCAR), Dectin-1, Dectin-2, DCIR3, and DC-SIGN [6]. This expression profile, in conjunction with the polarized expression of antigen processing and presentation machinery, contributes to the intrinsic functional difference between the DC subsets in regulating immunity [6]. In humans, C-type lectin ICAM3-grabbing nonintegrin (DC-SIGN, CD209) is expressed by mucosal DCs and langerin (CD207) is expressed by Langerhans cells [3,4]. Besides tissue DCs, macrophage, myeloid DCs (mDCs) and monocytes express a number of CLRs, such as Dectin-1, macrophage mannose receptor (MMR), and DCIR [3,4].
###end p 7
###begin p 8
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b007">7</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b008">8</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b009">9</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b005">5</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b010">10</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b011">11</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b010">10</xref>
###xml 334 339 <span type="species:ncbi:9606">human</span>
###xml 394 399 <span type="species:ncbi:9606">human</span>
Plasmacytoid DCs (pDCs), also referred to as natural type I interferon (IFN)-producing cells (IPCs), are a distinct DC population with an extraordinary ability to rapidly produce massive amounts of type I IFN in response to viral infections [7,8]. Blood dendritic cell antigen 2 (BDCA2), a C-type lectin uniquely expressed on resting human pDCs, has been used to unequivocally identify pDCs in human peripheral blood and tissues [9]. It has an intracellular N terminus and only one extracellular carbohydrate recognition domain, which belongs to the type II C-type lectin group [5,10,11]. Similar to CLRs on other DC subsets, BDCA2 has been suggested to be capable of functioning as an antigen-uptake receptor, because monoclonal antibodies (mAbs) bound to BDCA2 on the surface of pDCs are efficiently internalized, and mAb-derived peptide bound to MHC class II can be presented to T cells [10].
###end p 8
###begin p 9
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b012">12</xref>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b014">14</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b015">15</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b017">17</xref>
###xml 454 461 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(RIG-I)</italic>
###xml 506 512 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(MDA5)</italic>
###xml 560 567 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(IPS-1)</italic>
###xml 569 571 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b015">15</xref>
###xml 572 574 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b018">18</xref>
###xml 575 577 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b020">20</xref>
###xml 959 960 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b007">7</xref>
###xml 961 962 960 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b008">8</xref>
###xml 1277 1279 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b021">21</xref>
###xml 1280 1282 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b024">24</xref>
###xml 1072 1080 <span type="species:ncbi:9606">Patients</span>
Resting pDCs uniquely express high amounts of Toll-like receptor 9 (TLR9) and TLR7 [12-14], which recognize microbial DNA or RNA ligands in the endo-lysosomal compartment, respectively. After activation of TLR7 or TLR9, a multi-component "cytoplasmic transductional-transcriptional complex" is formed to initiate cellular activations [15-17]. Type I IFN production by pDCs has been shown to be independent of RNA helicases retinoic acid-inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA5) and their adaptor IFN-ss promoter stimulator-1 (IPS-1) [15,18-20], which are essential for IFN response to viruses by other immune or nonhematopoietic cells. Therefore, pDCs carry out their unique innate immune functions through the TLR-mediated pathway. After exposure to viruses, pDCs differentiate into efficient antigen-presenting DCs and thus act as a critical mediator linking innate and adaptive immune responses against viral infections [7,8]. However, aberrant pDC activation in the absence of infection has been associated with autoimmune diseases. Patients with active systemic lupus erythematosus (SLE) have high amounts of type I IFN in their sera, which is likely due to the activation of pDCs by autoantibodies complexed with self nuclear antigens [21-24]. Because both TLR7 and TLR9 are located intracellularly, how pDCs sense the extracellular microenvironment and, in turn, modulate these TLR-mediated responses remains an important question.
###end p 9
###begin p 10
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b025">25</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b026">26</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b025">25</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b011">11</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b027">27</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b028">28</xref>
###xml 818 820 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b029">29</xref>
###xml 821 823 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b030">30</xref>
BDCA2 was the first receptor described that negatively regulates the IFN response of pDCs, which is induced by CpG oligonucleotide, influenza virus, or by autoantibodies complexed with DNA [25,26]. However, it is not clear how BDCA2 modulates the TLR signaling, because its cytoplasmic domain does not contain any known signaling motifs, even though BDCA2 ligation by mAbs causes protein tyrosine phosphorylation and calcium influx [25]. A recent analysis of the closely related dendritic cell immunoreceptor family lectins, which include DCIR, DCAR, Dectin-2, and BDCA2, suggests a potential shared signaling mechanism as a result of the similar arrangement of their transmembrane domains [11,27,28]. Both DCAR and Dectin-2 have been shown to associate with FcepsilonRIgamma to transduce cellular activation signals [29,30].
###end p 10
###begin p 11
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 450 455 <span type="species:ncbi:9606">human</span>
Here we report that BDCA2 signals in pDCs by associating with the transmembrane adapter FcepsilonRIgamma and initiates an immunoreceptor-based tyrosine activation motif (ITAM)-dependent signaling cascade. We also provide evidence that human pDCs express a series of signaling molecules known to be specifically involved in BCR activation. We demonstrate that the BDCA2 and FcepsilonRIgamma complex activates a prominent BCR-like signaling pathway in human pDCs to modulate the TLR-mediated responses.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
BDCA2 Associates with and Signals through FcepsilonRIgamma
###end title 13
###begin p 14
###xml 271 279 271 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g001">Figure 1</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b009">9</xref>
###xml 442 443 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 609 617 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g001">Figure 1</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 259 264 <span type="species:ncbi:9606">human</span>
To determine the expression profile of BDCA2 in human leukocytes, we searched our established gene expression database, which includes the major immune cell types in peripheral blood. Strikingly, BDCA2 transcripts were expressed abundantly and exclusively by human pDCs (Figure 1A), consistent with its specific surface expression on pDCs within total peripheral blood mononuclear cell (PBMC) [9]. By contrast, immature peripheral blood CD11c+ mDC, monocyte, and monocyte-derived DC (mono-DC) expressed transcripts of other C-type lectins, such as DC-SIGN, Dectin-1, DCIR, and MMR, which were absent in pDCs (Figure 1A).
###end p 14
###begin title 15
BDCA2 Associates with FcepsilonRIgamma To Form a pDC-Specific Receptor Complex
###end title 15
###begin p 16
(A) The expression profile of BDCA2 transcripts in peripheral blood leukocytes by microarray gene expression analysis is shown. In comparison, the relative expression levels of DC-SIGN, Dectin-1, DCIR, and MMR are also shown. A value of <1 (arbitrary units) indicates the absence of gene expression.
###end p 16
###begin p 17
(B) Surface expression of BDCA2 after transduction of BDCA2 into Jurkat cells previously transfected with control, FcepsilonRIgamma, DAP12, DAP10, or a Y-F ITAM mutant FcepsilonRIgamma. The surface staining by isotype-matched control mAb is shown as a shaded area.
###end p 17
###begin p 18
(C) Co-immunoprecipitation of BDCA2 and FcepsilonRIgamma from BDCA2 and FcepsilonRIgamma doubly transfected Jurkat cells after cell surface biotinylation. Western blot analysis was performed with anti-FcepsilonRIgamma Ab or with HRP-conjugated NeutrAvidin.
###end p 18
###begin p 19
(D) Co-immunoprecipitation of BDCA2 and FcepsilonRIgamma from freshly isolated pDCs. Western blot analysis was performed with anti-FcepsilonRIgamma Ab.
###end p 19
###begin p 20
###xml 164 166 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
###xml 533 541 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g001">Figure 1</xref>
###xml 739 741 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
###xml 867 876 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg001">Figure S1</xref>
###xml 1193 1201 1133 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g001">Figure 1</xref>
###xml 1256 1264 1196 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g001">Figure 1</xref>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 698 703 <span type="species:ncbi:10090">mouse</span>
###xml 1244 1249 <span type="species:ncbi:9606">human</span>
pDCs express two transmembrane adapter proteins bearing ITAMs, i.e., FcepsilonRIgamma and DAP12, as well as DAP10, which signals via a YINM motif to activate PI3K [31]. To test whether BDCA2 interacts with any of these adapters, the individual adapters were first stably transduced into Jurkat cells, a human T cell line. When BDCA2 was transfected into Jurkat cells containing FcepsilonRIgamma, the expression of BDCA2 on the cell surface was greatly enhanced, indicating a potential interaction between BDCA2 and FcepsilonRIgamma (Figure 1B). In contrast, the presence of DAP12 and DAP10 only marginally affected BDCA2 expression, whereas both DAP12 and DAP10 increased the surface expression of mouse NKG2D, used as a positive control [31]. The enhanced BDCA2 surface expression in the presence of FcepsilonRIgamma was also observed in several T and B cell lines (Figure S1). To demonstrate directly the physical association between BDCA2 and FcepsilonRIgamma, we performed co-immunoprecipitation experiments and showed that FcepsilonRIgamma existed in a complex that could be precipitated by antibody to BDCA2, but not by an isotype-matched control antibody from transfected Jurkat cells (Figure 1C) and, furthermore, from freshly isolated human pDCs (Figure 1D). These data suggest that BDCA2 and FcepsilonRIgamma form a receptor complex with signaling potential.
###end p 20
###begin p 21
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b025">25</xref>
###xml 432 440 422 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g002">Figure 2</xref>
###xml 730 738 700 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g001">Figure 1</xref>
###xml 830 838 800 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g002">Figure 2</xref>
Previously, BDCA2-transfected Jurkat cells were shown to be unable to initiate protein tyrosine phosphorylation after BDCA2 crosslinking, an observation suggesting the potential involvement of a signaling adapter [25]. When BDCA2 was crosslinked on the Jurkat cells that were cotransfected with different adapters, Jurkat cells expressing FcepsilonRIgamma, but not DAP12 or DAP10, prominently phosphorylated a spectrum of proteins (Figure 2A). We constructed a mutant FcepsilonRIgamma in which the tyrosine (Y) residue within the intracellular ITAM was replaced with phenylalanine (F), rendering it unable to recruit downstream molecules. This mutant FcepsilonRIgamma supported the elevated levels of surface expression of BDCA2 (Figure 1B) but was unable to mediate the protein tyrosine phosphorylation after BDCA2 crosslinking (Figure 2B), indicating an essential role of the ITAM in FcepsilonRIgamma for the signaling by the BDCA2/FcepsilonRIgamma complex.
###end p 21
###begin title 22
Crosslinking the BDCA2/FcepsilonRIgamma Complex Transduces Activation Signals
###end title 22
###begin p 23
(A) Total protein phosphorylation in Jurkat cells transfected with BDCA2 in the absence or presence of adapter proteins by anti-BDCA2 mAb or control IgG1 crosslinking. Western blot analysis was performed with anti-phosphotyrosine mAb PY20.
###end p 23
###begin p 24
(B) Total protein phosphorylation induced by anti-BDCA2 mAb crosslinking in Jurkat cells transfected with BDCA2 and wild-type (WT) or mutant (Y-to-F) FcepsilonRIgamma.
###end p 24
###begin p 25
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
(C) Transfected mouse 2B4 T hybridoma cells with an NFAT-GFP reporter (transgenes are labeled on the top) were crosslinked with control mouse IgG1 or anti-BDCA2 mAb. Cells were analyzed for GFP expression by flow cytometry. Cells cultured in medium alone or with ionomycin (positive control) were also analyzed.
###end p 25
###begin p 26
(D) The kinetics of intracellular calcium flux in transfected Jurkat cells (transgenes are labeled on top) when crosslinked (marked by arrow) by control (IgG1) or anti-BDCA2 mAb.
###end p 26
###begin p 27
###xml 232 234 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
###xml 235 237 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b032">32</xref>
###xml 294 302 284 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g002">Figure 2</xref>
###xml 528 536 498 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g002">Figure 2</xref>
###xml 816 824 776 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g002">Figure 2</xref>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Furthermore, when a human BDCA2/FcepsilonRIgamma complex was introduced into a mouse T cell hybridoma line that contained an intracellular nuclear factor of activated T cells-green fluorescent protein (NFAT-GFP) reporter construct [31,32], crosslinking BDCA2 by mAb resulted in GFP expression (Figure 2C), indicating that the BDCA2/FcepsilonRIgamma receptor complex was able to activate NFAT, similar to the effect of TCR-induced activation. In the absence of FcepsilonRIgamma, crosslinking BDCA2 did not induce GFP expression (Figure 2C). Finally, calcium influx, one of the important cellular activation events that occurs downstream of ITAM signaling, was effectively triggered by BDCA2 crosslinking in Jurkat cells transfected with both BDCA2 and FcepsilonRIgamma, but not in cells transfected with BDCA2 alone (Figure 2D), further confirming the requirement of FcepsilonRIgamma for BDCA2 to signal.
###end p 27
###begin title 28
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human pDCs Express Signaling Molecules Involved in BCR Activation
###end title 28
###begin p 29
To further delineate the intracellular signaling events following BDCA2 and FcepsilonRIgamma activation, we examined the expression by pDCs of components known to be involved in ITAM-mediated signaling. In lymphocytes, several well-established signaling pathways exist downstream of the B cell and T cell antigen receptors, linked through ITAM-bearing subunits of these receptor complexes. We analyzed the expression of molecules involved in BCR and TCR activation in pDCs in comparison with peripheral B cells, T cells, natural killer (NK) cells, mDCs, and monocytes.
###end p 29
###begin p 30
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b033">33</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b034">34</xref>
###xml 874 882 873 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g003">Figure 3</xref>
###xml 996 1004 995 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g003">Figure 3</xref>
###xml 1317 1319 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b035">35</xref>
###xml 1361 1369 1360 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g003">Figure 3</xref>
###xml 1799 1807 1798 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g003">Figure 3</xref>
After receptor activation, two core tyrosine residues within the ITAM(s) are phosphorylated by Src family protein tyrosine kinases (PTKs). The phosphorylated tyrosines within the ITAMs associate with the src homology 2(SH2) domains of Syk-family PTKs, which in turn phosphorylate cell-type-specific intracellular adapters to initiate a multitude of signaling events. Each type of lymphocyte expresses and uses a distinct set of proteins to carry out the receptor-proximal signal transduction [33,34]. B cells express B lymphoid tyrosine kinase (BLK), Lyn kinase, spleen tyrosine kinase (Syk), and two adapter molecules, BLNK and BCAP, whereas T cells preferentially use two other Src-family PTKs, Fyn and Lck, and CD3xi-associated protein kinase (ZAP-70) from the Syk-family of PTKs, as well as alternative adapters, i.e., SLP-76 and linker for activation of T cells (LAT) (Figure 3A). Strikingly, pDCs express many members of the BCR signaling cascade, but not those involved in TCR activation (Figure 3A). Of note, the levels of the B cell-specific adapter B cell linker (BLNK, also known as SLP-65 or BASH) was transcribed at higher levels in pDC than in B cells (514 relative units versus 133 relative units, respectively). Another B cell adapter, BCAP, which mediates phosphoinositide-3-kinase (PI3K) signaling [35], was also abundantly expressed by pDCs (Figure 3A). pDCs expressed lower levels of BLK compared to B cells. Interestingly, NK cells, in addition to expressing several members of the TCR signaling pathway, were found also to express several molecules involved in BCR signaling, e.g., Lyn, Syk and BCAP. mDC and monocyte similarly express Lyn, Syk, BCAP, and Fyn as well as the T cell adaptor SLP76. However unlike pDCs and B cells, they both lack the expression of BLNK and BLK (Figure 3A). Within all the peripheral cell leukocytes we examined, BLNK transcripts were only transcribed by pDCs and B cells (unpublished data).
###end p 30
###begin title 31
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human pDCs Express a BCR-Like Signaling Cascade
###end title 31
###begin p 32
(A) Expression of genes encoding molecules involved in BCR (top panel) and TCR (bottom panel) signaling in six peripheral leukocyte cell types from microarray gene expression analysis.
###end p 32
###begin p 33
(B) The relative gene expression of signaling molecules in different cell types from three healthy donors determined by quantitative RT-PCR analysis. The expression was normalized with the level of the transcript in total PBMC. The median expression is marked by a horizontal bar.
###end p 33
###begin p 34
(C) The expression of signaling proteins in different cell types was determined by Western blot analysis. The results from one representative donor out of three healthy donors analyzed are shown.
###end p 34
###begin p 35
###xml 212 221 208 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg002">Figure S2</xref>
###xml 339 348 331 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg005">Figure S5</xref>
###xml 516 525 508 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg002">Figure S2</xref>
We next analyzed the expression of the signaling components operating downstream of the molecules described above. pDCs and B cells selectively transcribed PLCgamma2, Vav2, and Vav3, which are absent in T cells (Figure S2). On the other hand, high levels of PKCtheta are abundantly expressed by T and NK cells, but not by pDCs or B cells (Figure S5). In contrast, the expression of other downstream signaling molecules, such as PI3K, Nck, MAP kinases, and NFAT, failed to show a distinct cell type-specific pattern (Figure S2).
###end p 35
###begin p 36
###xml 167 175 167 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g003">Figure 3</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g003">3</xref>
###xml 392 400 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g004">Figure 4</xref>
###xml 288 293 <span type="species:ncbi:9606">human</span>
We confirmed the transcription and protein expression of the BCR proximal signaling molecules in pDCs from several healthy donors by RT-PCR and Western blot analysis (Figure 3B and 3C). Taken together, our analysis revealed the existence of a potential ITAM-mediated signaling cascade in human pDCs similar to that of B cells, but distinct from that in T cells, NK cells, monocytes, or mDCs (Figure 4).
###end p 36
###begin title 37
###xml 47 52 <span type="species:ncbi:9606">Human</span>
Diagram of ITAM-Mediated Signaling Pathways in Human Leukocytes
###end title 37
###begin p 38
The schematic cascades that are involved in receptor proximal signaling (solid arrows) and those leading to NF-kappaB activation (dotted lines) are shown.
###end p 38
###begin title 39
BDCA2/FcepsilonRIgamma Complex Transduces Signals via a BCR-Like Signaling Cascade
###end title 39
###begin p 40
###xml 404 412 374 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g005">Figure 5</xref>
###xml 583 585 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b036">36</xref>
###xml 655 663 625 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g004">Figure 4</xref>
###xml 797 805 763 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g005">Figure 5</xref>
###xml 956 964 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g005">Figure 5</xref>
###xml 1003 1005 969 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 132 137 <span type="species:ncbi:9606">human</span>
To investigate whether the BDCA2/FcepsilonRIgamma receptor complex could signal through the BCR signaling cascade, Namalwa cells, a human Burkitt lymphoma cell line, was transfected with BDCA2 and FcepsilonRIgamma. Similar to BCR activation, crosslinking of the BDCA2/FcepsilonRIgamma complex on Namalwa cells resulted in rapid phosphorylation of residue Y525 of Syk and residue Y416 of Src-family PTKs (Figure 5). After BCR activation, five tyrosine residues on BLNK are phosphorylated, enabling its function as a scaffold to integrate and propagate signals to downstream proteins [36]. BDCA2 ligation resulted in phosphorylation of residue Y84 of BLNK (Figure 4). Additional downstream molecules, such as Vav1 and PLCgamma2, were phosphorylated by BDCA2 crosslinking, similar to BCR activation (Figure 5). MAP kinases Erk1/2, which are also activated after BCR engagement through the Ras-Raf pathway, were rapidly phosphorylated after BDCA2 stimulation (Figure 5). Furthermore, we observed a robust Ca++ influx in Namalwa cells after BDCA2 crosslinking, which is dependent on FcepsilonRIgamma (unpublished data).
###end p 40
###begin title 41
BDCA2/FcepsilonRIgamma Complex Signals through the BCR Signaling Cascade in Transfected B Cells
###end title 41
###begin p 42
###xml 214 219 <span type="species:ncbi:9606">human</span>
Shown are the kinetics of tyrosine phosphorylation of BCR intracellular signaling components in transduced Namalwa cells when crosslinked by control IgG1 or anti-BDCA2 mAb in comparison with BCR activation by anti-human Ig Ab.
###end p 42
###begin p 43
###xml 217 225 207 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g006">Figure 6</xref>
###xml 472 480 462 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g006">Figure 6</xref>
###xml 756 764 746 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g006">Figure 6</xref>
###xml 964 972 954 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g006">Figure 6</xref>
###xml 1308 1316 1294 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g006">Figure 6</xref>
###xml 1525 1533 1511 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g006">Figure 6</xref>
###xml 1863 1872 1845 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg003">Figure S3</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 1152 1157 <span type="species:ncbi:9606">human</span>
###xml 1972 1977 <span type="species:ncbi:9606">human</span>
To study the signaling of the BDCA2/FcepsilonRIgamma complex in primary human pDCs, we crosslinked BDCA2 by mAbs on freshly isolated pDCs and confirmed that it potently induces a transient intracellular calcium flux (Figure 6A). This activity was inhibited by PP2, a compound that inhibits Src family PTKs, but was not affected by an inactive control compound, PP3. In addition, Syk inhibitor completely abolished the intracellular calcium flux in BDCA2-crosslinked pDCs (Figure 6A). These results suggest the functional involvement of both Syk and Src-family PTKs during BDCA2 signaling. When the phosphorylation status of key signaling molecules in pDCs was analyzed, BDCA2 crosslinking resulted in rapid phosphorylation of both Src family PTKs and Syk (Figure 6B), indicating the onset of ITAM-induced signaling in pDCs. Different from the results with the Namalwa cell line, BDCA2 crosslinking did not enhance the pre-existing phosphorylation of BLNK in pDCs (Figure 6B, lane 5). High levels of phosphorylation of Y84 in the BLNK protein have been observed in freshly isolated, resting pDCs from several healthy donors, but not in freshly isolated human B cells (unpublished data). Moreover, downstream molecules, including Vav1, PLCgamma2, and Erk1/2, were phosphorylated by BDCA2 crosslinking on pDCs (Figure 6B). In contrast, crosslinking with neither the isotype-matched control antibody nor the mAb against BDCA-4, another surface molecule expressed on pDCs, phosphorylated these proteins under the same conditions (Figure 6B). It should be noted that BDCA-4 beads were used to isolate pDCs, therefore BDCA-4 may no longer available for efficient crosslinking. The Src PTK inhibitor PP2 or Syk inhibitor, but not PP3, greatly diminished BDCA2-induced phosphorylation of both Src family PTKs and Syk and blocked the phosphorylation of Vav1 and PLCgamma2 (Figure S3). Thus, the BDCA2/FcepsilonRIgamma complex signals through a BCR-like signaling cascade in primary human pDCs.
###end p 43
###begin title 44
BDCA2/FcepsilonRIgamma Complex Signals through a BCR-Like Signaling Cascade in Primary pDCs
###end title 44
###begin p 45
(A) The kinetics of intracellular calcium flux in freshly isolated pDCs when crosslinked (marked by arrow) by control IgG1 or anti-BDCA2 Ab. As indicated, cells were pre-incubated with PP2, PP3, or Syk inhibitor prior to crosslinking.
###end p 45
###begin p 46
(B) The kinetics of tyrosine phosphorylation on BCR intracellular signaling components in freshly isolated pDCs when crosslinked by control IgG1, anti-BDCA2 mAb, or anti-BDCA-4 mAb.
###end p 46
###begin title 47
BDCA2/FcepsilonRIgamma Complex Signaling Inhibits TLR-Mediated Type I IFN Production
###end title 47
###begin p 48
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b037">37</xref>
###xml 344 346 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b038">38</xref>
###xml 425 433 411 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g007">Figure 7</xref>
###xml 638 646 610 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g007">Figure 7</xref>
###xml 223 228 <span type="species:ncbi:9606">human</span>
Although BCR signaling synergizes with TLR triggering for optimal B lymphocyte activation [37], the impact of this pathway on TLR-mediated type I IFN responses needs to be defined. To accomplish this, we stably transfected human Burkitt lymphoma Namalwa cells with IRF7, BDCA2 and FcepsilonRIgamma. These cells with endogenous TLR9 expression [38] produced IFNalpha in response to stimulation with CpG oligonucleotide (ODN) (Figure 7A). Crosslinking of BDCA2/FcepsilonRIgamma or BCR together with CpG activation in these Namalwa cells resulted in enhanced interleukin 10 (IL-10) production, as expected, but decreased IFNalpha secretion (Figure 7A), indicating a selective suppressive effect by BCR or BDCA2 activation on TLR-induced IFNalpha production.
###end p 48
###begin title 49
Ligation of the BDCA2/FcepsilonRIgamma Complex Inhibits TLR-Induced Type I IFN Production
###end title 49
###begin p 50
(A) Transfected Namalwa cells were stimulated with CpG ODN and ligated with anti-BDCA2, anti-BCR, or control mAbs. Shown are the amounts of IFNalpha and IL-10 secreted by the cells stimulated CpG in a triplicate assay.
###end p 50
###begin p 51
###xml 234 235 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(B) Purified pDCs were stimulated by CpG (top panel) or R848 (bottom panel) following anti-BDCA2 or control mAb crosslinking. The amounts of the secreted IFNalpha, TNFalpha, and IL-6 in a triplicate assay from a representative donor (n >/= 3) are shown.
###end p 51
###begin p 52
###xml 206 207 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(C) Purified pDCs stimulated by CpG first and then treated with anti-BDCA2 or control mAbs at different time intervals. The amounts of the secreted IFNalpha, TNFalpha, and IL-6 from a representative donor (n >/= 3) are shown.
###end p 52
###begin p 53
(D) The amounts of type I IFN transcripts were determined by quantitative RT-PCR analysis. The expression is shown as the relative level of transcription compared with unstimulated PBMC.
###end p 53
###begin p 54
###xml 528 536 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g007">Figure 7</xref>
###xml 703 712 680 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg004">Figure S4</xref>
###xml 162 167 <span type="species:ncbi:9606">human</span>
To investigate the function of the BCR-like signaling cascade in pDCs, we analyzed, in detail, the impact of BDCA2 crosslinking on the innate immune responses of human primary pDCs. Purified pDCs were stimulated with CpG ODN 2216 or R848, ligands of TLR9 and TLR7 or TLR8, respectively, in the presence of anti-BDCA2 mAb or control mAbs. BDCA2 ligation potently inhibited IFNalpha production and invariably reduced the production of tumor necrosis factor alpha (TNFalpha) and IL-6 induced by stimulation with these TLR ligands (Figure 7B). pDCs secreted lower levels of IFNalpha after BDCA2 ligation, but normal amounts of chemokines CXCL10/IP-10, CCL3/MIP-1alpha and CCL4/MIP-1beta in response to CpG (Figure S4).
###end p 54
###begin p 55
###xml 345 353 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g007">Figure 7</xref>
###xml 669 678 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg005">Figure S5</xref>
###xml 933 942 917 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg005">Figure S5</xref>
To evaluate the kinetics of BDCA2-mediated suppression of IFN production, pDCs were first stimulated with CpG and control or anti-BDCA2 mAbs were added to the culture at different times afterward. Strikingly, up to 4 h after pDCs were exposed to CpG ODN, crosslinking BDCA2 by mAb effectively inhibited IFNalpha and cytokine production by pDCs (Figure 7C). This result demonstrates the potency of BDCA2 to inhibit the TLR-induced innate immune responses by pDCs. Independently, pDCs from multiple donors were stimulated simultaneously with both CpG and anti-BDCA2 or control mAbs and at different lapsed times, the amounts of IFNalpha in the supernatant were measured (Figure S5). At 4 h after CpG treatment, pDCs treated with anti-BDCA2 mAbs reduced the production of IFNalpha by 96%. By 8 h post CpG treatment, BDCA2-ligated pDCs produced an average of 25.6% of IFNalpha compared to the amount made by control IgG1-incubated pDCs (Figure S5). Therefore, BDCA2 crosslinking likely blocked the initial induction of IFNalpha secretion.
###end p 55
###begin p 56
###xml 327 335 312 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g007">Figure 7</xref>
To further determine the stage of IFN suppression, we measured the amount of type I IFN transcripts from CpG-activated pDCs that were crosslinked with anti-BDCA2 or control mAbs. BDCA2 crosslinking uniformly reduced the transcription of all the subtypes of type I IFN analyzed, i.e., IFNalpha, IFNbeta, IFNgamma, and IFNomega (Figure 7D). Therefore, BDCA2 ligation blocks the transcriptional of type I IFN by pDCs in response to TLR activation.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 356 361 <span type="species:ncbi:9606">human</span>
To date, BDCA2 is the only C-type lectin that is found expressed exclusively on human pDCs, and it serves as a defining marker for pDCs. In addition, BDCA2 represents one of the most potent receptors that modulates the ability of pDCs to elicit type I IFN responses. Here we provide experimental evidence to reveal the signaling mechanism used by BDCA2 in human pDCs. On the cell surface, BDCA2 associates with FcepsilonRIgamma to form a signaling receptor complex, which, upon ligation, activates a novel BCR-like intracellular signaling cascade, interfering with TLR activation.
###end p 58
###begin p 59
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b039">39</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b041">41</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b042">42</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b043">43</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b050">50</xref>
###xml 995 997 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b051">51</xref>
###xml 998 1000 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b052">52</xref>
###xml 1210 1218 1200 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g007">Figure 7</xref>
###xml 1407 1409 1397 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b053">53</xref>
###xml 1410 1412 1400 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b054">54</xref>
###xml 1582 1584 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b055">55</xref>
###xml 1585 1587 1567 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b057">57</xref>
###xml 1590 1599 1572 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-sg006">Figure S6</xref>
###xml 1604 1612 1586 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050248-g007">Figure 7</xref>
###xml 450 455 <span type="species:ncbi:9606">human</span>
ITAM-based signaling is the primary pathway of activation used by classical immunoreceptors, such as the antigen receptors on B and T lymphocytes, NK cell receptors, and the Fc receptors on myeloid cells [39-41]. ITAM-mediated signaling is also used by additional receptors, such as cell adhesion molecules, chemokine receptors, plexins, and lectin receptors [42]. pDC and mDCs represent two major subsets of professional antigen-presenting cells in human peripheral blood and tissues, which use different sets of pattern recognition receptors, such as TLRs, CLRs, and Nod-like receptors, for sensing and responding to microbial infections [43-50]. Our present study suggests that mDCs and pDCs not only express different repertories of lectin receptors, but also suggests that the signal pathways used by CLRs bearing ITAM elements on mDC and pDCs are intrinsically different. Ligation of either the BDCA2/FcepsilonRIgamma complex or certain myeloid cell lectins, such as Dectin-1 and DC-SIGN [51,52], phosphorylates Syk, which is involved in BCR membrane-proximal signaling. However, downstream of Syk, pDCs use the intracellular adaptor molecule BLNK, whereas mDCs use SLP76 for amplification of signaling (Figure 7). In addition, recent studies showed that CARD9, a signaling adaptor molecule, plays a critical role in the signal transduction of Dectin-1 and ITAM-associated receptors in myeloid cells [53,54]. Our analysis suggests that similar to lymphocytes, pDCs do not express CARD9, but likely use CARMA1 (also named CARD11) to activate nuclear factor kappaB (NF-kappaB) [55-57] (Figure S6 and Figure 7).
###end p 59
###begin p 60
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b012">12</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b014">14</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b058">58</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b059">59</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b061">61</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b059">59</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b062">62</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b063">63</xref>
Previous studies have shown remarkable similarities between B lineage cells and pDCs, including their plasma cell morphology and shared expression of several classes of genes. For example, they express a similar sets of TLRs (TLR7 and TLR9) [12,14,58], possess germ-line immunoglobulin (Ig) transcripts and Ig recombinase [59-61], have B cell-related transcription factor Spi-B [59,62], and use the same CIITA promoter for the controlling of MHC Class II expression [63]. The present demonstration that the pDC receptor BDCA2/FcepsilonRIgamma and BCR share the same membrane-proximal signaling cascade and pathway leading to NF-kappaB activation provides further support for the intriguing relationship between pDCs and B lymphocytes.
###end p 60
###begin p 61
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b034">34</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b036">36</xref>
###xml 380 382 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b036">36</xref>
A central mediator during B cell activation, BLNK, is phosphorylated by BCR activation on five tyrosine residues (Y72, Y84, Y96, Y178, and Y189) that serve as docking sites for recruiting downstream molecules [34,36]. Interestingly, in resting primary pDCs, we observed high levels of, if not saturating, phosphorylation of Y84 in BLNK, which is involved in PLCgamma2 activation [36]. Further examination of tyrosine phosphorylation on other residues of BLNK may shed light on the dynamic involvement of this key molecule in nucleating signaling components during BDCA2 activation.
###end p 61
###begin p 62
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b064">64</xref>
###xml 292 318 292 318 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b065">65</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b066">66</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 128 131 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 191 194 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 292 318 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 450 463 <span type="species:ncbi:11234">measles virus</span>
###xml 465 467 <span type="species:ncbi:11234">MV</span>
###xml 515 520 <span type="species:ncbi:9606">human</span>
###xml 600 602 <span type="species:ncbi:11234">MV</span>
A recent study reported that BDCA2 may serve as an alternative receptor, in addition to CD4, CXCR4, and CCR5 on human pDCs, for HIV via binding to gp120 [64]. Therefore, it is plausible that HIV uptake by BDCA2 negatively affects the ability of pDCs to mount type I IFN responses. Similarly, Mycobacterium tuberculosis targets DC-specific C-type lectin DC-SIGN to infect DCs and to directly down-regulate DC-mediated immune responses [65]. Moreover, measles virus (MV) interacts with CD46, its cellular receptor on human monocytes, to specifically down-regulate IL-12 production, a mechanism causing MV-induced immunosuppression [66]. Therefore, BDCA2 may represent another example of antigen uptake receptors targeted by microbial ligands to negatively regulate cellular immunity.
###end p 62
###begin p 63
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b010">10</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b017">17</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b067">67</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b070">70</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b024">24</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b071">71</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b072">72</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b073">73</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b074">74</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b075">75</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b076">76</xref>
Paradoxically, activation by antigens through the BCR triggers B cell proliferation, differentiation, and Ig and cytokine production, whereas crosslinking of BDCA2, which activates a similar BCR-like signaling pathway, fails to stimulate pDCs to proliferate or produce cytokines [10] (W. Cao, unpublished data), but rather inhibits the TLR-mediated responses. As multiple receptors on pDCs apparently use ITAM-based mechanisms to modulate type I IFN and cytokine responses during TLR activation [17,31,67-70], our findings will facilitate further investigations to determine how TLR activation is regulated in pDCs. Such mechanisms may provide opportunities for therapeutic interventions in autoimmune diseases, such as SLE [24], Sjogren syndrome [71,72], polymyositis [73,74], and psoriasis [75,76], where the causative mechanisms might involve hyper-activation of pDCs.
###end p 63
###begin title 64
Materials and Methods
###end title 64
###begin title 65
Media, cell lines, and reagents.
###end title 65
###begin p 66
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
RPMI-1640 medium supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 ng/ml streptomycin (Invitrogen; ), and heat-inactivated 10% FBS (Atlanta Biologicals; ) were used for the cell culture. The human acute T cell leukemia cell line Jurkat and the Burkitt lymphoma cell line Namalwa were purchased from the American Type Culture Collection (ATCC). The mouse 2B4 T hybridoma cell line was generously provided by H. Arase, Osaka University, Japan. CpG ODN 2216 (GGGGGACGATCGTCGG-GGGG and CpG 2006 (TCGTCGTTTTGTCGT-TTTGTCGTT) (Qiagen; ) and R848 (InVivogen; ) were used for pDC stimulation.
###end p 66
###begin title 67
Immune cell isolation and establishment of gene expression database.
###end title 67
###begin p 68
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 516 517 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 521 522 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 526 527 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 630 631 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 634 635 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 650 651 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 660 661 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 667 668 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 673 674 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 680 681 680 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 694 695 694 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 698 699 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 704 705 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 714 715 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 719 720 719 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 724 725 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 731 732 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 758 759 758 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 762 763 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 766 767 766 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 771 772 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 776 777 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 781 782 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 794 795 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 191 196 <span type="species:ncbi:9606">human</span>
The institutional review board for human research at the M.D. Anderson Cancer Center approved this study. Our gene expression database containing multiple types of immune cells isolated from human peripheral blood was established as described [31]. For this study, four peripheral leukocyte cell types were isolated simultaneously from buffy coats of individual healthy donors. Briefly, pDCs were positively selected from PBMC with anti-BDCA-4-coated microbeads and sorted by flow cytometry as CD3-CD4+CD8-CD11c-CD14-CD16-CD19-CD56-. The remaining PBMCs were stained and individual cell types were sorted accordingly: B cells (CD4-CD8-CD11c-CD14-CD16-CD19+CD56-CD235a-BDCA2-), CD4+ T cells (CD4+CD8-CD11c-CD14-CD16-CD19-CD56-CD235a-BDCA2-), and NK cells (CD3-CD4-CD8-CD14-CD19-CD56+CD235a-BDCA2-).
###end p 68
###begin title 69
Quantitative real-time PCR.
###end title 69
###begin p 70
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
###xml 138 146 138 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050248-st001">Table S1</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
Total RNA extraction and quantitative real-time (RT)-PCR were performed as described [31]. Oligonucleotide primers used are listed in the Table S1 or described previously [31].
###end p 70
###begin title 71
Cloning and expression of BDCA2 and transmembrane adapters.
###end title 71
###begin p 72
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b077">77</xref>
###xml 419 421 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b031">31</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 352 357 <span type="species:ncbi:9606">human</span>
Full-length human BDCA2 was cloned from cDNAs generated from human peripheral blood pDCs by high-fidelity PCR using the following primers: sense, ATATGGATCCATGGTGCCTGAAGAA-GAGC and antisense, CTATGAATTCTTATATGT-AGATCTTCTTCATC. The BDCA2 cDNA was then cloned into the Bam HI and Eco RI sites of a lentiviral vector FG-30 [77]. Full-length cDNA encoding human FcepsilonRIgamma, DAP12, and DAP10, as described previously [31], were subcloned into FG-30. An FcepsilonRIgamma mutant with Y-to-F substitution in the ITAM was prepared by PCR and cloned into the FG-30 lentiviral vector for gene transduction.
###end p 72
###begin title 73
NFAT-GFP reporter cell assays.
###end title 73
###begin p 74
###xml 159 161 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050248-b032">32</xref>
###xml 201 202 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Both BDCA2 and FcepsilonRIgamma, or each cDNA individually, were transduced into mouse 2B4 T hybridoma cells stably expressing an NFAT-GFP reporter construct [32]. Transfected cells were cultured at 106 cells/ml in the presence of 10 mug/ml of plate-bound anti-BDCA2 mAb AC144 (Miltenyi Biotec; ) or purified IgG1 isotype-matched control mAb (eBioscience; ) for 20 h and then analyzed for GFP expression by flow cytometry.
###end p 74
###begin title 75
Cell surface biotinylation and protein immunoprecipitation.
###end title 75
###begin p 76
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
###xml 763 769 <span type="species:ncbi:9986">rabbit</span>
###xml 863 867 <span type="species:ncbi:9925">goat</span>
###xml 873 879 <span type="species:ncbi:9986">rabbit</span>
2 x 107 cells that were pre-washed with phosphate-buffered saline (PBS) were incubated with 2 mM EZ-Link Sulfo-NHS-LC-Biotin (Pierce Biotechnology; ) according to manufacturer's protocol. Cells were then washed 3 time with 100 mM glycine in 1x PBS, and lysed in Brij-NP-40 lysis buffer (0.875% Brij 97, 0.125% Nonidet P-40, 10 mM Tris base, pH 8.0, 150 mM NaCl plus protease inhibitors). Then the lysates were cleared by a spin at 10,000g for 10 min. The lysates were incubated with either control mouse IgG1 or anti-BDCA2 mAb conjugated to Protein G-Sepharose (Pierce Biotechnology) at 4 degreesC overnight. The sepharose beads were washed extensively with the lysis buffer before elution of the antigen with SDS sample buffer. Western blots were performed with rabbit anti- FcepsilonRIgamma antibody (gift from Dr. M-H Jouvin, BIDMC, Boston) and HRP-conjugated goat anti-rabbit IgG or HRP-labeled neutravidin (Pierce Biotechnology).
###end p 76
###begin title 77
Western blot analysis of protein tyrosine phosphorylation and expression.
###end title 77
###begin p 78
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 180 181 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 291 292 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 338 339 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 182 186 <span type="species:ncbi:9925">goat</span>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 293 297 <span type="species:ncbi:9925">goat</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
5 x 105 cells transfected with BDCA2 and FcepsilonRIgamma were incubated with control mouse IgG1 (eBioscience) or anti-BDCA2 mAb (Miltenyi Biotec), and then crosslinked with F(ab')2 goat anti-mouse IgG (Jackson ImmunoResearch Lab; ). BCR crosslinking was performed by adding 15 mug/ml F(ab')2 goat anti-human Ig (Southern Biotech). 5 x 105 pDCs isolated using a BDCA-4 cell isolation kit (Miltenyi Biotec) were incubated with control mouse IgG1, anti-BDCA2, or anti-BDCA-4 mAb (Miltenyi Biotec). Western blot was performed with anti-phospho Src family Ab, anti-phospho Syk Ab, anti-phospho Erk1/2, anti-non-phospho Src family Ab, anti-Syk Ab (Cell Signaling Technology; ), anti-phospho BLNK, anti-phospho Vav1 (Abcam; ), anti-phospho PLCgamma2 (BD Biosciences; ), and anti-beta-actin mAb (Sigma; ).
###end p 78
###begin title 79
Calcium influx assay.
###end title 79
###begin p 80
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
106 transfected cells or pDCs, pre-loaded with Fluo4- and Fura Red-AM (Invitrogen), were crosslinked as described above and analyzed on a FACSAria (BD Biosciences) and data were evaluated by using FlowJo software (TreeStar; ). As indicated, cells were pre-incubated for 30 min with 25 muM PP2, 25 muM PP3, or 5 muM Syk inhibitor (EMD Biosciences; ) prior to crosslinking.
###end p 80
###begin title 81
Namalwa transfectants.
###end title 81
###begin p 82
###xml 512 513 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 186 191 <span type="species:ncbi:9606">human</span>
###xml 514 518 <span type="species:ncbi:9925">goat</span>
###xml 524 529 <span type="species:ncbi:9606">human</span>
###xml 636 641 <span type="species:ncbi:9606">human</span>
Namalwa cells were transduced sequentially by lentiviral vectors expressing human IRF7, BDCA2, and FcepsilonRIgamma. Full-length human IRF7 was cloned from cDNAs generated from purified human peripheral pDCs using a high-fidelity Taq polymerase (Invitrogen) with primers; sense, ACCTCTAGAATGGCCTTGGCTCCTGAGAGG, and antisense, ATTCTCGAGCTAGGCGGGCTGCTCCAGCTCC. The transduced Namalwa cells were stimulated with CpG ODN 2006 and then cultured in the presence of 10 mug/ml of plate-bound anti-BDCA2 mAb AC144, F(ab')2 goat anti-human Ig, or purified control IgG1 for 20 h. Supernatants were analyzed for cytokine secretion by ELISA using a human IFNalpha kit (Bender MedSystems; ) and IL-10 kit (R&D Systems; ).
###end p 82
###begin title 83
BDCA2 crosslinking on pDCs in culture.
###end title 83
###begin p 84
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 438 443 <span type="species:ncbi:9606">human</span>
5 x 104 pDCs isolated by enrichment with anti-BDCA-4-coated microbeads and subsequent flow cytometry (CD4+CD11c-CD3-CD14-CD16-CD19-CD56-) were incubated with 5 mug/ml anti-BDCA2 or control mAb in 100 mul culture medium for 30 min prior to stimulation with 1 muM CpG 2216 or 0.05 mug/ml of R848. Cells and supernatants were harvested 18 h later for real-time quantitative PCR analysis and enzyme-linked immunosorbent assay (ELISA) using a human IFNalpha kit (Bender MedSystems), IFNalpha kit (PBL Biomedical Laboratories; ), IL-6 kit, TNFalpha kit, CXCL10 kit, CCL3 kit, and CCL4 kit (R&D Systems). For kinetic studies, pDCs were stimulated with 1 muM CpG 2216 and co-cultured with anti-BDCA2 or control mAbs at time 0. At different time points, supernatants were harvested for quantitation of cytokines or IFN by ELISA. Alternatively, CpG was added first to pDC cultures, and then anti-BDCA2 or control mAbs were added at different times thereafter. Eighteen h after addition of CpG, supernatants were harvested for quantitation of cytokines or IFN by ELISA.
###end p 84
###begin title 85
Supporting Information
###end title 85
###begin title 86
###xml 99 104 <span type="species:ncbi:10090">Mouse</span>
###xml 125 130 <span type="species:ncbi:9606">Human</span>
###xml 175 180 <span type="species:ncbi:9606">Human</span>
Expression Levels of BDCA2 in the Presence and Absence of FcepsilonRIgamma on Transfected T Cells (Mouse 2B4 T Hybridoma and Human Jurkat Cell Lines) and Transfected B Cells (Human HPB-Null Cell Line)
###end title 86
###begin p 87
(79 KB PPT)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin title 89
Relative Transcription of Intracellular Molecules Involved in Antigen Receptor Signaling in Four Lymphoid Cell Types Based on Microarray Gene Expression Analysis
###end title 89
###begin p 90
(57 KB PPT)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin title 92
Blocking of Tyrosine Phosphorylation of BCR-Like Intracellular Signaling Components Induced by BDCA2 Crosslinking by Inhibitors of Src PTK or Syk in Freshly Isolated pDCs
###end title 92
###begin p 93
(276 KB PDF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin title 95
Crosslinking of BDCA2 Inhibits TLR-Induced IFNbeta but Not Chemokine Production
###end title 95
###begin p 96
###xml 197 198 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Purified pDCs were stimulated by CpG following anti-BDCA2 or control Ab crosslinking. The amounts of secreted IFNbeta, CXCL10/IP-10, CCL3/MIP-1alpha and CCL4/MIP-1beta from a representative donor (n >/= 3) are shown.
###end p 96
###begin p 97
(49 KB PPT)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin title 99
Purified pDCs Were Co-Stimulated by CpG and mAbs (Anti-BDCA2 or Control IgG) for 4 or 8 Hours
###end title 99
###begin p 100
The relative amounts of the secreted IFNalpha from four donors are shown. The median expression is marked by a horizontal bar. The numbers on top of the symbols indicate the average amounts of IFNalpha (pg/ml) present in the culture supernatant.
###end p 100
###begin p 101
(44 KB PPT)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin title 103
Relative Transcription of Intracellular Molecules Involved in NF-kappaB Activation in Peripheral Immune Cells Based on Microarray Gene Expression Analysis
###end title 103
###begin p 104
(49 KB PPT)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin title 106
Oligonucleotide Primers Used
###end title 106
###begin p 107
(26 KB DOC)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
The authors are grateful to Karen Ramirez, Zhiwei He, and Eric Wieder for cell sorting and technical support. We also thank Dr. Xiaofeng Qin for help on lentivirus constructions. LLL is an American Cancer Society Research Professor. DBR is supported by a Genentech Graduate Student Fellowship and a UCSF Chancellor's Research Fellowship.
###end p 109
###begin title 110
Abbreviations
###end title 110
###begin p 111
B cell receptor
###end p 111
###begin p 112
blood dendritic cell antigen 2
###end p 112
###begin p 113
C-type lectin receptor
###end p 113
###begin p 114
dendritic cell
###end p 114
###begin p 115
dendritic cell immunoreceptor
###end p 115
###begin p 116
green fluorescent protein
###end p 116
###begin p 117
interferon
###end p 117
###begin p 118
immunoreceptor-based tyrosine activation motif
###end p 118
###begin p 119
monoclonal antibody
###end p 119
###begin p 120
myeloid DC
###end p 120
###begin p 121
nuclear factor of activated T cells
###end p 121
###begin p 122
nuclear factor kappaB
###end p 122
###begin p 123
natural killer cell
###end p 123
###begin p 124
plasmacytoid DC
###end p 124
###begin p 125
protein tyrosine kinase
###end p 125
###begin p 126
T cell receptor
###end p 126
###begin p 127
Toll-like receptor
###end p 127
###begin title 128
References
###end title 128
###begin article-title 129
Dendritic cells: Specialized and regulated antigen processing machines
###end article-title 129
###begin article-title 130
Dendritic cells and the control of immunity
###end article-title 130
###begin article-title 131
Dendritic cells: Translating innate to adaptive immunity
###end article-title 131
###begin article-title 132
Self- and nonself-recognition by C-type lectins on dendritic cells
###end article-title 132
###begin article-title 133
Dual function of C-type lectin-like receptors in the immune system
###end article-title 133
###begin article-title 134
Differential antigen processing by dendritic cell subsets in vivo
###end article-title 134
###begin article-title 135
Plasmacytoid dendritic cells in immunity
###end article-title 135
###begin article-title 136
IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors
###end article-title 136
###begin article-title 137
###xml 85 90 <span type="species:ncbi:9606">human</span>
BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood
###end article-title 137
###begin article-title 138
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon a/b induction
###end article-title 138
###begin article-title 139
Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells
###end article-title 139
###begin article-title 140
###xml 11 16 <span type="species:ncbi:9606">human</span>
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
###end article-title 140
###begin article-title 141
###xml 72 77 <span type="species:ncbi:9606">human</span>
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells
###end article-title 141
###begin article-title 142
###xml 79 84 <span type="species:ncbi:9606">human</span>
Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
###end article-title 142
###begin article-title 143
Innate immune recognition of viral infection
###end article-title 143
###begin article-title 144
Regulation of the type I IFN induction: a current view
###end article-title 144
###begin article-title 145
Innate immune functions of plasmacytoid dendritic cells
###end article-title 145
###begin article-title 146
Antiviral defense: Interferons and beyond
###end article-title 146
###begin article-title 147
Cell type-specific involvement of RIG-I in antiviral response
###end article-title 147
###begin article-title 148
The specific and essential role of MAVS in antiviral innate immune responses
###end article-title 148
###begin article-title 149
###xml 35 40 <span type="species:ncbi:9606">human</span>
The emerging role of interferon in human systemic lupus erythematosus
###end article-title 149
###begin article-title 150
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
###end article-title 150
###begin article-title 151
Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus
###end article-title 151
###begin article-title 152
The central role of dendritic cells and interferon-alpha in SLE
###end article-title 152
###begin article-title 153
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon a/b induction
###end article-title 153
###begin article-title 154
Plasmacytoid dendritic cells: From specific surface markers to specific cellular functions
###end article-title 154
###begin article-title 155
Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2
###end article-title 155
###begin article-title 156
###xml 21 26 <span type="species:ncbi:9606">human</span>
Molecular cloning of human Dectin-2
###end article-title 156
###begin article-title 157
Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor g chain
###end article-title 157
###begin article-title 158
Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses
###end article-title 158
###begin article-title 159
Plasmacytoid dendritic cell-specific receptor ILT7-FceRIg inhibits Toll-like receptor-induced interferon production
###end article-title 159
###begin article-title 160
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors
###end article-title 160
###begin article-title 161
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling
###end article-title 161
###begin article-title 162
SLP76 and SLP65: Complex regulation of signalling in lymphocytes and beyond
###end article-title 162
###begin article-title 163
BCAP: The tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation
###end article-title 163
###begin article-title 164
BLNK: Molecular scaffolding through 'cis'-mediated organization of signaling proteins
###end article-title 164
###begin article-title 165
CpG motifs in bacterial DNA trigger direct B-cell activation
###end article-title 165
###begin article-title 166
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides
###end article-title 166
###begin article-title 167
Role of ITAM-containing adapter proteins and their receptors in the immune system and bone
###end article-title 167
###begin article-title 168
Immune inhibitory receptors
###end article-title 168
###begin article-title 169
Natural killer cell receptor signaling
###end article-title 169
###begin article-title 170
The expanding role for ITAM-based signaling pathways in immune cells
###end article-title 170
###begin article-title 171
Inferences, questions and possibilities in Toll-like receptor signalling
###end article-title 171
###begin article-title 172
Toll-like receptor function and signaling
###end article-title 172
###begin article-title 173
Toll-like receptors: Linking innate and adaptive immunity
###end article-title 173
###begin article-title 174
Macrophage receptors and imune recognition
###end article-title 174
###begin article-title 175
Myeloid C-type lectins in innate immunity
###end article-title 175
###begin article-title 176
C-type lectin receptors on dendritic cells and Langerhans cells
###end article-title 176
###begin article-title 177
Nod-like proteins in immunity, inflammation and disease
###end article-title 177
###begin article-title 178
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation
###end article-title 178
###begin article-title 179
DC-SIGN: Escape mechanism for pathogens
###end article-title 179
###begin article-title 180
Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins
###end article-title 180
###begin article-title 181
Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity
###end article-title 181
###begin article-title 182
The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors
###end article-title 182
###begin article-title 183
Antigen-receptor signaling to nuclear factor kappaB
###end article-title 183
###begin article-title 184
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
###end article-title 184
###begin article-title 185
CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B
###end article-title 185
###begin article-title 186
A role for Toll-like receptors in acquired immunity: Up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells
###end article-title 186
###begin article-title 187
###xml 133 138 <span type="species:ncbi:9606">human</span>
Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells
###end article-title 187
###begin article-title 188
###xml 24 29 <span type="species:ncbi:9606">human</span>
Origin and filiation of human plasmacytoid dendritic cells
###end article-title 188
###begin article-title 189
Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin
###end article-title 189
###begin article-title 190
The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development
###end article-title 190
###begin article-title 191
MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells
###end article-title 191
###begin article-title 192
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-alpha secretion in plasmacytoid dendritic cells
###end article-title 192
###begin article-title 193
Mycobacteria target DC-SIGN to suppress dendritic cell function
###end article-title 193
###begin article-title 194
###xml 54 67 <span type="species:ncbi:11234">measles virus</span>
Mechanism of suppression of cell-mediated immunity by measles virus
###end article-title 194
###begin article-title 195
TLR9- and FceRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression
###end article-title 195
###begin article-title 196
Characterization of FceRI-bearing CD123+ blood dendritic cell antigen-2+ plasmacytoid dendritic cells in atopic dermatitis
###end article-title 196
###begin article-title 197
###xml 24 29 <span type="species:ncbi:9606">human</span>
Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44
###end article-title 197
###begin article-title 198
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12
###end article-title 198
###begin article-title 199
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome
###end article-title 199
###begin article-title 200
Induction of interferon-a by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA
###end article-title 200
###begin article-title 201
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
###end article-title 201
###begin article-title 202
Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis
###end article-title 202
###begin article-title 203
Plasmacytoid predendritic cells initiate psoriasis through interferon-a production
###end article-title 203
###begin article-title 204
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors
###end article-title 204
###begin article-title 205
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5
###end article-title 205
###begin p 206
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. WC conceived, designed, and performed the experiments. LZ analyzed the data. DRB and GW performed some experiments. LB and MB prepared reagents. WC, LLL, and YJL had extensive scientific discussion for this study and wrote the paper.
###end p 206
###begin p 207
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This study was supported by the M.D. Anderson Cancer Foundation (YJL) and the National Institutes of Health grant AI068129 (DBR and LLL).
###end p 207
###begin p 208
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 208

